Beiersdorf stock gains 3.02% as NIVEA turnaround stays in focus
Published on 11/04/2026 at 17:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey Beiersdorf developments
- HSBC has adopted a more cautious view as weaker NIVEA shopper sales limit expectations for growth and margin improvement.
- Derma, La Prairie and Healthcare continue to offset part of the pressure on NIVEA and tesa.
- Beiersdorf has kept its 2026 sales and margin guidance unchanged.
Beiersdorf stock traded at 85.69 euros on Lang & Schwarz at 17:11 CET on Wednesday, November 4, 2026, 3.02 percent above the Xetra close of Tuesday, November 3. The comparison uses the previous Xetra session because Wednesday's Xetra session had not yet reached the 17:35 CET threshold.
The real-time quote of Beiersdorf stock is available on the company snapshot page.
HSBC flags a slower recovery
In a November 2 report, Investing.com, citing Reuters, said HSBC downgraded Beiersdorf from Buy to Hold and cut its price target from 90 euros to 88 euros. The bank linked its more cautious view to slower NIVEA sales to shoppers and limited room for margin improvement in 2027.
HSBC also reduced its 2027 earnings-per-share forecast from 4.22 euros to 4.17 euros and its adjusted operating-margin estimate from 12.2 percent to 12 percent. The bank said a cautious pricing strategy could make it harder to offset higher raw-material and packaging costs.
Growth offsets remain important
Beiersdorf's third-quarter release on October 27 showed a mixed operating picture. According to the company's third-quarter results, group organic sales declined 1.3 percent, while NIVEA organic sales fell 4.9 percent. Tesa sales declined 4.3 percent as semiconductor shortages affected its Electronics business.
Derma sales grew 10.6 percent organically, La Prairie advanced 8.5 percent and Healthcare increased 5.7 percent. These businesses offer important portfolio support, but the NIVEA turnaround remains the central test for a stronger recovery.
Guidance stays unchanged
Beiersdorf continues to expect a low-single-digit organic sales decline at group level in 2026 and an EBIT margin excluding special factors of at least 11.8 percent. The Consumer segment margin target remains at least 11.0 percent.
Germany's DAX provides the relevant broader market context for Beiersdorf's domestic listing.
Further developments will center on NIVEA's execution, inventory normalization and the contribution from the faster-growing brands. More news and analyses on Beiersdorf stock track these factors.
Beiersdorf stock at a glance
- Company: Beiersdorf AG
- ISIN: DE0005200000
- Ticker: BEI.DE
- Lang & Schwarz quote: 85.69 euros at 17:11 CET on November 4, 2026
- Daily change: 3.02 percent versus the Xetra close of November 3, 2026
- Xetra close: 83.18 euros on November 3, 2026
